Get expert market intelligence solutions tailored for sales professionals, managers, and executives.
When healthcare providers raise concerns about switching from current medications, validate their concerns while highlighting your product's unique benefits. Address pricing objections by emphasizing patient assistance programs and insurance coverage. For formulary restrictions, demonstrate the clinical value proposition and cost-effectiveness data. Combat "no time to see sales reps" by offering concise, data-driven presentations that respect their schedule.
In pharma sales, closing isn't about aggressive tactics but rather about achieving mutual agreement on patient benefits. Focus on securing meaningful commitments like: agreeing to prescribe for specific patient profiles, requesting samples for eligible patients, or scheduling follow-up discussions about clinical data. Build your closing approach around clinical evidence, patient outcomes, and therapeutic advantages. Use techniques like the summary close ("Based on the clinical data we've discussed, would you consider prescribing for patients with condition X?") or the trial close ("Would you be interested in evaluating this treatment with your next five eligible patients?").
